Nine panels have formed at ICSID in recent weeks, including a first appointment at the centre for Debevoise & Plimpton’s former co-chair of dispute resolution David W Rivkin.
14 February 2024
Eight new tribunals have formed at ICSID in recent weeks, including first-time appointments for retired UK Supreme Court justice Lord Hope, Three Crowns partner Constantine Partasides KC, Spain's José Antonio Caínzos and Brazil’s Adriana Braghetta.
11 January 2024
Quinn Emanuel has promoted Julianne Jaquith to partner and Odysseas Repousis to of counsel in its US offices – while three other disputes lawyers with arbitration experience have also joined the partnership.
03 January 2024
An Italian contractor is pursuing a billion-dollar ICC claim against a company operated by Canada’s TC Energy over a project to build a natural gas pipeline that was delayed by covid-19 and protests from indigenous communities.
14 December 2023
Reed Smith’s former international arbitration practice head and Latin America specialist José Astigarraga is leaving the firm next year to become an independent arbitrator and mediator.
29 November 2023
A Canadian court has refused to revive a US$3 billion NAFTA claim against Mexico despite finding that the conduct of the state’s appointed arbitrator gave rise to a reasonable apprehension of bias.
31 October 2023
Martin Valasek has left his role as head of Norton Rose Fulbright’s international arbitration practice in Canada to join Bennett Jones, with Alison FitzGerald also joining as partner.
30 October 2023
Eight new panels have formed at ICSID in recent weeks, including first-time appointments for Irish barrister Michael Collins SC, DLA Piper’s Kamau Karori and Mohamed Shelbaya of GBS Disputes.
20 October 2023
A panel at Hong Kong Arbitration Week discussed the future of Russian and CIS disputes – including whether Hong Kong is a preferred option for parties from the region, how sanctions affect the handling of cases and the potential for asking a tribunal to move a previously agreed seat.
17 October 2023
An Indian biotech company says that its Canadian partner has filed an US$118 million ICC claim over their collaboration to develop drugs.
06 October 2023
Unlock unlimited access to all Global Arbitration Review content